BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20939180)

  • 1. [Overexpression of synuclein-gamma confers resistance to antimicrotubule drugs against human hepatoma cells].
    Cheng SX; Zhang S; Zhang H; Song DQ; Wang YP; Li YH; You XF; Wang YM; Jiang JD
    Yao Xue Xue Bao; 2010 Jun; 45(6):724-9. PubMed ID: 20939180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of SNCG transfection on the effectiveness of anti-tumor drugs in PC-3 cell lines].
    Chen JL; Wang B; Zhang LR; He BS; Pan YQ; Zeng QD; Jiang HX; Wang SK
    Zhonghua Nan Ke Xue; 2008 Dec; 14(12):1077-82. PubMed ID: 19157226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.
    Zhou Y; Inaba S; Liu J
    Int J Oncol; 2006 Jul; 29(1):289-95. PubMed ID: 16773211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs.
    Singh VK; Zhou Y; Marsh JA; Uversky VN; Forman-Kay JD; Liu J; Jia Z
    Cancer Res; 2007 Jan; 67(2):626-33. PubMed ID: 17234772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.
    Zhao W; Liu H; Liu W; Wu Y; Chen W; Jiang B; Zhou Y; Xue R; Luo C; Wang L; Jiang JD; Liu J
    Int J Oncol; 2006 May; 28(5):1081-8. PubMed ID: 16596223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of stathmin-mediated microtubule destabilization sensitizes retinoblastoma cells to a low dose of antimicrotubule agents: a novel synergistic therapeutic intervention.
    Mitra M; Kandalam M; Sundaram CS; Verma RS; Maheswari UK; Swaminathan S; Krishnakumar S
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5441-8. PubMed ID: 21546534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of IRF9 confers resistance to antimicrotubule agents in breast cancer cells.
    Luker KE; Pica CM; Schreiber RD; Piwnica-Worms D
    Cancer Res; 2001 Sep; 61(17):6540-7. PubMed ID: 11522652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells.
    Inaba S; Li C; Shi YE; Song DQ; Jiang JD; Liu J
    Breast Cancer Res Treat; 2005 Nov; 94(1):25-35. PubMed ID: 16142440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel and vincristine potentiate adenoviral oncolysis that is associated with cell cycle and apoptosis modulation, whereas they differentially affect the viral life cycle in non-small-cell lung cancer cells.
    AbouEl Hassan MA; Braam SR; Kruyt FA
    Cancer Gene Ther; 2006 Dec; 13(12):1105-14. PubMed ID: 16841078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
    Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
    Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-122 sensitizes HCC cancer cells to adriamycin and vincristine through modulating expression of MDR and inducing cell cycle arrest.
    Xu Y; Xia F; Ma L; Shan J; Shen J; Yang Z; Liu J; Cui Y; Bian X; Bie P; Qian C
    Cancer Lett; 2011 Nov; 310(2):160-9. PubMed ID: 21802841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells.
    Sun BT; Zheng LH; Bao YL; Yu CL; Wu Y; Meng XY; Li YX
    Eur J Pharmacol; 2011 Mar; 654(2):129-34. PubMed ID: 21195709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
    Ranganathan S; McCauley RA; Dexter DW; Hudes GR
    Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in gamma-actin and tubulin-targeted drug resistance in childhood leukemia.
    Verrills NM; Po'uha ST; Liu ML; Liaw TY; Larsen MR; Ivery MT; Marshall GM; Gunning PW; Kavallaris M
    J Natl Cancer Inst; 2006 Oct; 98(19):1363-74. PubMed ID: 17018783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Construction, expression and immune response of eukaryotic plasmid secreting SNCG].
    Meng L; Jiang B; Zhao W; Zhao L; Liu C; Wu J; Shou C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):626-30. PubMed ID: 20649033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
    Thomadaki H; Floros KV; Scorilas A
    Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer.
    Czekierdowski A; Czekierdowska S; Wielgos M; Smolen A; Kaminski P; Kotarski J
    Neuro Endocrinol Lett; 2006 Jun; 27(3):381-6. PubMed ID: 16816827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin-dependent kinase 1 inhibitor RO3306 promotes mitotic slippage in paclitaxel-treated HepG2 cells.
    Xiao J; Qiu P; Lai X; He P; Wu Y; Du B; Tan Y
    Neoplasma; 2014; 61(1):41-7. PubMed ID: 24195507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.
    Liu H; Zhou Y; Boggs SE; Belinsky SA; Liu J
    Oncogene; 2007 Aug; 26(40):5900-10. PubMed ID: 17369845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of N-Ras by shRNA-expressing plasmid increases sensitivity of HepG2 cells to vincristine-induced growth inhibition.
    Sun HX; He HW; Zhang SH; Liu TG; Ren KH; He QY; Shao RG
    Cancer Gene Ther; 2009 Sep; 16(9):693-702. PubMed ID: 19247395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.